<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00249795</url>
  </required_header>
  <id_info>
    <org_study_id>EFC4912 I</org_study_id>
    <secondary_id>Clopidogrel (SR25990)</secondary_id>
    <nct_id>NCT00249795</nct_id>
  </id_info>
  <brief_title>Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)</brief_title>
  <acronym>ACTIVE I</acronym>
  <official_title>A Parallel Randomized Controlled Evaluation of Clopidogrel Plus Aspirin, With Factorial Evaluation of Irbesartan, for the Prevention of Vascular Events, in Patients With Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bristol-Myers Squibb</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Sanofi</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to determine if Irbesartan compared to Placebo would reduce the
      risk of vascular events such as heart attack, stroke, non-cerebral thromboembolic event and
      death in patients with Atrial Fibrillation (AF) and with at least one major risk of vascular
      events.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ACTIVE I was one of the 3 separate but related trials of the ACTIVE program conducted in AF
      patients at risk of vascular events.

      Patients were enrolled first into one of the 2 parallel trials of the ACTIVE program
      evaluating Clopidogrel:

        -  ACTIVE A comparing clopidogrel + acetylsalicylic acid (ASA) and ASA alone

        -  ACTIVE W comparing clopidogrel + ASA and oral anticoagulant (OAC).

      Then those satisfying additional criteria related to blood pressure and angiotensin receptor
      blocking agents were re-randomized in the two ACTIVE I arms according to a separate
      randomization list.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2003</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>First Occurence of Any Component of the Composite of Myocardial Infarction, Stroke or Vascular Death as Per Adjudication</measure>
    <time_frame>Median follow-up of 4.5 years</time_frame>
    <description>The first co-primary event is the first occurence of any component of the following cluster over the duration of follow-up: myocardial infarction (nonfatal or fatal), stroke (nonfatal or fatal) or vascular death - after validation by the Event Adjudication Committee (EAC).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>First Occurence of Any Component of the Composite of Myocardial Infarction, Stroke, Vascular Death or Hospitalization for Heart Failure as Per Adjudication</measure>
    <time_frame>Median follow-up of 4.5 years</time_frame>
    <description>The second co-primary event is the first occurence of any component of the following cluster over the duration of follow-up: myocardial infarction (nonfatal or fatal), stroke (nonfatal or fatal), vascular death or hospitalization for heart failure - after validation by the EAC.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>First Occurrence of Stroke</measure>
    <time_frame>Median follow-up of 4.5 years</time_frame>
    <description>The considered event is the first occurrence of stroke (nonfatal or fatal, ischemic, hemorrhagic or of uncertain type) over the duration of follow-up, after validation by the EAC.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death From Any Cause</measure>
    <time_frame>Median follow-up of 4.5 years</time_frame>
    <description>The considered event is the death over the duration of the follow-up whatever the cause, cardiovascular or non-cardiovascular.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First Occurrence of Any Heart Failure (HF) Episode</measure>
    <time_frame>Median follow-up of 4.5 years</time_frame>
    <description>The considered event is the first occurence of any HF episode defined as evidence of signs and symptoms of HF with or without hospitalization over the duration of follow-up, as reported by the investigator (i.e. not validated by the Event Adjudication Committee).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First Hospitalisation for Heart Failure (HF)</measure>
    <time_frame>Median follow-up of 4.5 years</time_frame>
    <description>The considered event is the first overnight hospital stay for HF over the duration of the follow-up, after validation by the EAC.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First Hospitalisation for Other Cardiovascular (CV) Cause</measure>
    <time_frame>Median follow-up of 4.5 years</time_frame>
    <description>The considered event is the overnight hospital stay for any CV cause other than Heart Failure over the duration of follow-up, as reported by the investigator (i.e. not validated by the Event Adjudication Committee).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">9016</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Irbesartan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>150 mg for 2 weeks, then up-titrated to 300 mg up to final follow-up visit</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matching placebo up to final follow-up visit</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Irbesartan</intervention_name>
    <description>oral administration (tablets) once daily</description>
    <arm_group_label>Irbesartan</arm_group_label>
    <other_name>Aprovel®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>oral administration (tablets) once daily</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Should fulfill the eligibility criteria for ACTIVE A or ACTIVE W trial and:

          -  have a systolic blood pressure of at least 110 mmHg

          -  not already receiving an angiotensin receptor blocking agent, unless they are willing
             and able to be changed to another antihypertensive agent

          -  no previous intolerance to angiotensin receptor blocking agents

          -  no proven indication for angiotensin receptor blocking agents, unless an Angiotensin
             Converting Enzyme (ACE) inhibitor can be substituted

        Exclusion Criteria:

        Patients will be excluded from ACTIVE study if any of the following are present:

          -  requirement for clopidogrel (such as recent coronary stent procedure)

          -  requirement for oral anticoagulant (such as prosthetic mechanical heart valve)

          -  prior intolerance to acetylsalicyclic acid (ASA) or clopidogrel

          -  documented peptic ulcer disease within the previous 6 months

          -  prior intracerebral hemorrhage

          -  significant thrombocytopenia (platelet count &lt;50 x 10(9)/L)

          -  psychosocial reason making study participation impractical

          -  geographic reason making study participation impractical

          -  ongoing alcohol abuse

          -  mitral stenosis

          -  pregnant or nursing woman or woman of child bearing potential and not on effective
             birth control for at least one month prior to start of study or not willing to
             continue on birth control for duration of study

          -  severe comorbid condition such that the patient is not expected to survive 6 months

          -  patient currently receiving an investigational pharmacologic agent

          -  requirement for chronic (&gt; 3 months) non-cyclooxygenase-2 (non-COX-2) inhibitor
             nonsteroidal anti-inflammatory drug (NSAID) therapy unless willing enrolled in ACTIVE
             A
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Salim YUSUF, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Hamilton Health Sciences Corporation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Bridgewater</city>
        <state>New Jersey</state>
        <zip>08807</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Macquarie Park</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Wien</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Diegem</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Sao Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Laval</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Praha</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Horsholm</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Causeway Bay</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Mexico</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Gouda</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Lysaker</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Warszawa</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Porto Salvo</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Midrand</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Bromma</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Geneva</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanofi-Aventis Administrative Office</name>
      <address>
        <city>Guildford Surrey</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>Czech Republic</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hong Kong</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Malaysia</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Singapore</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Taiwan</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Israel</country>
    <country>Russian Federation</country>
    <country>Turkey</country>
  </removed_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 4, 2005</study_first_submitted>
  <study_first_submitted_qc>November 4, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2005</study_first_posted>
  <results_first_submitted>August 24, 2010</results_first_submitted>
  <results_first_submitted_qc>September 29, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 15, 2010</results_first_posted>
  <last_update_submitted>September 29, 2010</last_update_submitted>
  <last_update_submitted_qc>September 29, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 15, 2010</last_update_posted>
  <responsible_party>
    <name_title>ICD Study Director</name_title>
    <organization>Sanofi-aventis</organization>
  </responsible_party>
  <keyword>Atrial fibrillation</keyword>
  <keyword>Cardiovascular disease</keyword>
  <keyword>angiotensin II blocker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clopidogrel</mesh_term>
    <mesh_term>Irbesartan</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were enrolled in 567 centers in 33 countries. They were initially to be followed until November 2008. After a blinded reassessment of the event rate in May 2008, the planned follow-up end date was postponed and was actually completed on August 2009 corresponding to an actual median follow-up of 4.5 years.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Irbesartan</title>
          <description>150 mg for 2 weeks, then uptitrated to 300 mg up to final follow-up visit</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>matching placebo up to final follow-up visit</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4518">randomized patients: patients remained in the study whether treated or not until planned study end</participants>
                <participants group_id="P2" count="4498">randomized patients: patients remained in the study whether treated or not until planned study end</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3124">started and completed study drug</participants>
                <participants group_id="P2" count="3108">started and completed study drug</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1394"/>
                <participants group_id="P2" count="1390"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Not treated</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Symptomatic hypotension</title>
              <participants_list>
                <participants group_id="P1" count="127"/>
                <participants group_id="P2" count="64"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other Serious Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="84"/>
                <participants group_id="P2" count="93"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Qualifying condition not present</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="29"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="678"/>
                <participants group_id="P2" count="742"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Thromboembolic / outcome event</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Oral anticoagulant required</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Minor bleeding (e.g.,bruising,epistaxis)</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Non-compliance</title>
              <participants_list>
                <participants group_id="P1" count="71"/>
                <participants group_id="P2" count="69"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Study drug intolerance</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other adverse events (non-serious)</title>
              <participants_list>
                <participants group_id="P1" count="188"/>
                <participants group_id="P2" count="159"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician withdrew consent</title>
              <participants_list>
                <participants group_id="P1" count="71"/>
                <participants group_id="P2" count="63"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Surgery / procedure</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Angiotensin II receptor blocker required</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="58"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lightheadedness / dizziness</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Hypotension (non-symptomatic)</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other contraindicated medication</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Event related to cardiac condition</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Patient not wish to continue after May08</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Site not agree to continue after May08</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Missing</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Irbesartan</title>
          <description>150 mg for 2 weeks, then uptitrated to 300 mg up to final follow-up visit</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>matching placebo up to final follow-up visit</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="4518"/>
            <count group_id="B2" value="4498"/>
            <count group_id="B3" value="9016"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.5" spread="9.7"/>
                    <measurement group_id="B2" value="69.6" spread="9.7"/>
                    <measurement group_id="B3" value="69.6" spread="9.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>18 to &lt;65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1287"/>
                    <measurement group_id="B2" value="1255"/>
                    <measurement group_id="B3" value="2542"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>65 to &lt;75 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1684"/>
                    <measurement group_id="B2" value="1673"/>
                    <measurement group_id="B3" value="3357"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=75 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1547"/>
                    <measurement group_id="B2" value="1570"/>
                    <measurement group_id="B3" value="3117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1773"/>
                    <measurement group_id="B2" value="1768"/>
                    <measurement group_id="B3" value="3541"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2745"/>
                    <measurement group_id="B2" value="2730"/>
                    <measurement group_id="B3" value="5475"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Congestive heart failure, High blood pressure, Age, Diabetes Stroke 2 (CHADS2) Score</title>
          <description>7-point, ordinal score determining the risk of stroke from 0 (absence of risk) to 6 (higher risk) depending on the presence or absence of co-morbidities such as history of Congestive heart failure, hypertension, Age, history of Diabetes, previous Stroke.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>0</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="103"/>
                    <measurement group_id="B2" value="96"/>
                    <measurement group_id="B3" value="199"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1687"/>
                    <measurement group_id="B2" value="1678"/>
                    <measurement group_id="B3" value="3365"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1516"/>
                    <measurement group_id="B2" value="1560"/>
                    <measurement group_id="B3" value="3076"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt; 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1210"/>
                    <measurement group_id="B2" value="1163"/>
                    <measurement group_id="B3" value="2373"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sitting Systolic Blood Pressure</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;120 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="509"/>
                    <measurement group_id="B2" value="500"/>
                    <measurement group_id="B3" value="1009"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=120 mmHg</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4006"/>
                    <measurement group_id="B2" value="3996"/>
                    <measurement group_id="B3" value="8002"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <units>kg/m²</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.129" spread="5.614"/>
                    <measurement group_id="B2" value="28.867" spread="5.420"/>
                    <measurement group_id="B3" value="28.998" spread="5.519"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ACTIVE A / ACTIVE W</title>
          <description>Distribution of the patients according to their initial randomization in the ACTIVE program</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>ACTIVE A: clopidogrel + ASA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1263"/>
                    <measurement group_id="B2" value="1231"/>
                    <measurement group_id="B3" value="2494"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ACTIVE A: ASA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1245"/>
                    <measurement group_id="B2" value="1259"/>
                    <measurement group_id="B3" value="2504"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ACTIVE W: clopidogrel + ASA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1011"/>
                    <measurement group_id="B2" value="959"/>
                    <measurement group_id="B3" value="1970"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ACTIVE W: OAC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="999"/>
                    <measurement group_id="B2" value="1049"/>
                    <measurement group_id="B3" value="2048"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>First Occurence of Any Component of the Composite of Myocardial Infarction, Stroke or Vascular Death as Per Adjudication</title>
        <description>The first co-primary event is the first occurence of any component of the following cluster over the duration of follow-up: myocardial infarction (nonfatal or fatal), stroke (nonfatal or fatal) or vascular death - after validation by the Event Adjudication Committee (EAC).</description>
        <time_frame>Median follow-up of 4.5 years</time_frame>
        <population>The intent-to-treat (ITT) population was used for all analyses. This consisted of all randomized patients irrespective of whether or not the patient actually received study drug or the patient's compliance with the study protocol. All patients were included in the treatment group to which they were originally allocated.</population>
        <group_list>
          <group group_id="O1">
            <title>Irbesartan</title>
            <description>150 mg for 2 weeks, then uptitrated to 300 mg up to final follow-up visit</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>matching placebo up to final follow-up visit</description>
          </group>
        </group_list>
        <measure>
          <title>First Occurence of Any Component of the Composite of Myocardial Infarction, Stroke or Vascular Death as Per Adjudication</title>
          <description>The first co-primary event is the first occurence of any component of the following cluster over the duration of follow-up: myocardial infarction (nonfatal or fatal), stroke (nonfatal or fatal) or vascular death - after validation by the Event Adjudication Committee (EAC).</description>
          <population>The intent-to-treat (ITT) population was used for all analyses. This consisted of all randomized patients irrespective of whether or not the patient actually received study drug or the patient's compliance with the study protocol. All patients were included in the treatment group to which they were originally allocated.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4518"/>
                <count group_id="O2" value="4498"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>All components</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="963"/>
                    <measurement group_id="O2" value="963"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>- Myocardial Infarction (fatal or not)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="136"/>
                    <measurement group_id="O2" value="123"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>- Stroke (fatal or not)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="367"/>
                    <measurement group_id="O2" value="407"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>- Vascular death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="460"/>
                    <measurement group_id="O2" value="433"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.8570</p_value>
            <p_value_desc>The cumulative incidence function of this event was calculated for each treatment group using the non-parametric Kaplan-Meier method and the comparison was performed using a 2-sided Log Rank test at 4.5% level to account for multiplicity.</p_value_desc>
            <method>Log Rank</method>
            <method_desc>Logrank statistic was stratified on ACTIVE A/W strata.</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.992</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.907</ci_lower_limit>
            <ci_upper_limit>1.085</ci_upper_limit>
            <estimate_desc>HR was estimated using a Cox's proportional hazard model stratified on ACTIVE A/W strata with treatment group factor. It provides the relative hazard of any component of the composite event in Irbesartan group versus Placebo group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>First Occurence of Any Component of the Composite of Myocardial Infarction, Stroke, Vascular Death or Hospitalization for Heart Failure as Per Adjudication</title>
        <description>The second co-primary event is the first occurence of any component of the following cluster over the duration of follow-up: myocardial infarction (nonfatal or fatal), stroke (nonfatal or fatal), vascular death or hospitalization for heart failure - after validation by the EAC.</description>
        <time_frame>Median follow-up of 4.5 years</time_frame>
        <population>The intent-to-treat (ITT) population was used for this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Irbesartan</title>
            <description>150 mg for 2 weeks, then uptitrated to 300 mg up to final follow-up visit</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>matching placebo up to final follow-up visit</description>
          </group>
        </group_list>
        <measure>
          <title>First Occurence of Any Component of the Composite of Myocardial Infarction, Stroke, Vascular Death or Hospitalization for Heart Failure as Per Adjudication</title>
          <description>The second co-primary event is the first occurence of any component of the following cluster over the duration of follow-up: myocardial infarction (nonfatal or fatal), stroke (nonfatal or fatal), vascular death or hospitalization for heart failure - after validation by the EAC.</description>
          <population>The intent-to-treat (ITT) population was used for this analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4518"/>
                <count group_id="O2" value="4498"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>All components</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1236"/>
                    <measurement group_id="O2" value="1291"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>- Myocardial Infarction (fatal or not)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="122"/>
                    <measurement group_id="O2" value="112"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>- Stroke (fatal or not)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="340"/>
                    <measurement group_id="O2" value="375"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>- Vascular death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="331"/>
                    <measurement group_id="O2" value="291"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>- Hospitalization for heart failure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="443"/>
                    <measurement group_id="O2" value="513"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.1200</p_value>
            <p_value_desc>The cumulative incidence function of this event was calculated for each treatment group using the non-parametric Kaplan-Meier method and the comparison was performed using a 2-sided Log Rank test at 1% level to account for multiplicity.</p_value_desc>
            <method>Log Rank</method>
            <method_desc>Logrank statistic was stratified on ACTIVE A/W strata.</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.940</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.869</ci_lower_limit>
            <ci_upper_limit>1.016</ci_upper_limit>
            <estimate_desc>HR was estimated using a Cox's proportional hazard model stratified on ACTIVE A/W strata with treatment group factor. It provides the relative hazard of any component of the composite event in Irbesartan group versus Placebo group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>First Occurrence of Stroke</title>
        <description>The considered event is the first occurrence of stroke (nonfatal or fatal, ischemic, hemorrhagic or of uncertain type) over the duration of follow-up, after validation by the EAC.</description>
        <time_frame>Median follow-up of 4.5 years</time_frame>
        <population>The intent-to-treat (ITT) population was used for this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Irbesartan</title>
            <description>150 mg for 2 weeks, then uptitrated to 300 mg up to final follow-up visit</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>matching placebo up to final follow-up visit</description>
          </group>
        </group_list>
        <measure>
          <title>First Occurrence of Stroke</title>
          <description>The considered event is the first occurrence of stroke (nonfatal or fatal, ischemic, hemorrhagic or of uncertain type) over the duration of follow-up, after validation by the EAC.</description>
          <population>The intent-to-treat (ITT) population was used for this analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4518"/>
                <count group_id="O2" value="4498"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="379"/>
                    <measurement group_id="O2" value="411"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.2162</p_value>
            <p_value_desc>The cumulative incidence function of this event was calculated for each treatment group using the non-parametric Kaplan-Meier method and the comparison was performed using a 2-sided Log Rank test at 5% level.</p_value_desc>
            <method>Log Rank</method>
            <method_desc>Logrank statistic was stratified on ACTIVE A/W strata.</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.916</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.796</ci_lower_limit>
            <ci_upper_limit>1.053</ci_upper_limit>
            <estimate_desc>HR was estimated using a Cox's proportional hazard model stratified on ACTIVE A/W strata with treatment group factor. It provides the relative hazard of a stroke in Irbesartan group versus Placebo group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Death From Any Cause</title>
        <description>The considered event is the death over the duration of the follow-up whatever the cause, cardiovascular or non-cardiovascular.</description>
        <time_frame>Median follow-up of 4.5 years</time_frame>
        <population>The intent-to-treat (ITT) population was used for the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Irbesartan</title>
            <description>150 mg for 2 weeks, then uptitrated to 300 mg up to final follow-up visit</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>matching placebo up to final follow-up visit</description>
          </group>
        </group_list>
        <measure>
          <title>Death From Any Cause</title>
          <description>The considered event is the death over the duration of the follow-up whatever the cause, cardiovascular or non-cardiovascular.</description>
          <population>The intent-to-treat (ITT) population was used for the analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4518"/>
                <count group_id="O2" value="4498"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="949"/>
                    <measurement group_id="O2" value="929"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.7590</p_value>
            <p_value_desc>The cumulative incidence function of this event was calculated for each treatment group using the non-parametric Kaplan-Meier method and the comparison was performed using a 2-sided Log Rank test at 5% level.</p_value_desc>
            <method>Log Rank</method>
            <method_desc>Logrank statistic was stratified on ACTIVE A/W strata.</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.014</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.927</ci_lower_limit>
            <ci_upper_limit>1.110</ci_upper_limit>
            <estimate_desc>HR was estimated using a Cox's proportional hazard model stratified on ACTIVE A/W strata with treatment group factor. It provides the relative hazard of death in Irbesartan group versus Placebo group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>First Occurrence of Any Heart Failure (HF) Episode</title>
        <description>The considered event is the first occurence of any HF episode defined as evidence of signs and symptoms of HF with or without hospitalization over the duration of follow-up, as reported by the investigator (i.e. not validated by the Event Adjudication Committee).</description>
        <time_frame>Median follow-up of 4.5 years</time_frame>
        <population>The intent-to-treat (ITT) population was used for the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Irbesartan</title>
            <description>150 mg for 2 weeks, then uptitrated to 300 mg up to final follow-up visit</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>matching placebo up to final follow-up visit</description>
          </group>
        </group_list>
        <measure>
          <title>First Occurrence of Any Heart Failure (HF) Episode</title>
          <description>The considered event is the first occurence of any HF episode defined as evidence of signs and symptoms of HF with or without hospitalization over the duration of follow-up, as reported by the investigator (i.e. not validated by the Event Adjudication Committee).</description>
          <population>The intent-to-treat (ITT) population was used for the analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4518"/>
                <count group_id="O2" value="4498"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="699"/>
                    <measurement group_id="O2" value="767"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0369</p_value>
            <p_value_desc>The cumulative incidence function of this event was calculated for each treatment group using the non-parametric Kaplan-Meier method and the comparison was performed using a 2-sided Log Rank test at 5% level.</p_value_desc>
            <method>Log Rank</method>
            <method_desc>Logrank statistic was stratified on ACTIVE A/W strata.</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.897</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.809</ci_lower_limit>
            <ci_upper_limit>0.993</ci_upper_limit>
            <estimate_desc>HR was estimated using a Cox's proportional hazard model stratified on ACTIVE A/W strata with treatment group factor. It provides the relative hazard of HF episodes in Irbesartan group versus Placebo group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>First Hospitalisation for Heart Failure (HF)</title>
        <description>The considered event is the first overnight hospital stay for HF over the duration of the follow-up, after validation by the EAC.</description>
        <time_frame>Median follow-up of 4.5 years</time_frame>
        <population>The intent-to-treat (ITT) population was used for this analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Irbesartan</title>
            <description>150 mg for 2 weeks, then uptitrated to 300 mg up to final follow-up visit</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>matching placebo up to final follow-up visit</description>
          </group>
        </group_list>
        <measure>
          <title>First Hospitalisation for Heart Failure (HF)</title>
          <description>The considered event is the first overnight hospital stay for HF over the duration of the follow-up, after validation by the EAC.</description>
          <population>The intent-to-treat (ITT) population was used for this analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4518"/>
                <count group_id="O2" value="4498"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="482"/>
                    <measurement group_id="O2" value="551"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0175</p_value>
            <p_value_desc>The cumulative incidence function of this event was calculated for each treatment group using the non-parametric Kaplan-Meier method and the comparison was performed using a 2-sided Log Rank test at 5% level.</p_value_desc>
            <method>Log Rank</method>
            <method_desc>Logrank statistic was stratified on ACTIVE A/W strata.</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.863</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.763</ci_lower_limit>
            <ci_upper_limit>0.975</ci_upper_limit>
            <estimate_desc>HR was estimated using a Cox's proportional hazard model stratified on ACTIVE A/W strata with treatment group factor. It provides the relative hazard of hospitalization for Heart Failure in Irbesartan group versus Placebo group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>First Hospitalisation for Other Cardiovascular (CV) Cause</title>
        <description>The considered event is the overnight hospital stay for any CV cause other than Heart Failure over the duration of follow-up, as reported by the investigator (i.e. not validated by the Event Adjudication Committee).</description>
        <time_frame>Median follow-up of 4.5 years</time_frame>
        <population>The intent-to-treat (ITT) population was used for the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Irbesartan</title>
            <description>150 mg for 2 weeks, then uptitrated to 300 mg up to final follow-up visit</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>matching placebo up to final follow-up visit</description>
          </group>
        </group_list>
        <measure>
          <title>First Hospitalisation for Other Cardiovascular (CV) Cause</title>
          <description>The considered event is the overnight hospital stay for any CV cause other than Heart Failure over the duration of follow-up, as reported by the investigator (i.e. not validated by the Event Adjudication Committee).</description>
          <population>The intent-to-treat (ITT) population was used for the analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4518"/>
                <count group_id="O2" value="4498"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1186"/>
                    <measurement group_id="O2" value="1174"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.8377</p_value>
            <p_value_desc>The cumulative incidence function of this event was calculated for each treatment group using the non-parametric Kaplan-Meier method and the comparison was performed using a 2-sided Log Rank test at 5% level.</p_value_desc>
            <method>Log Rank</method>
            <method_desc>Logrank statistic was stratified on ACTIVE A/W strata.</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.008</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.930</ci_lower_limit>
            <ci_upper_limit>1.093</ci_upper_limit>
            <estimate_desc>HR was estimated using a Cox's proportional hazard model stratified on ACTIVE A/W strata with treatment group factor. It provides the relative hazard of hospitalization for other CV cause in Irbesartan group versus Placebo group.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From randomization until 14 days after treatment discontinuation or final follow-up visit whichever come first.</time_frame>
      <desc>The safety analysis was also carried out on the intent-to-treat (ITT) population to allow a benefit/risk assessment within the same study population.</desc>
      <group_list>
        <group group_id="E1">
          <title>Irbesartan</title>
          <description>150 mg for 2 weeks, then uptitrated to 300 mg up to final follow-up visit</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>matching placebo up to final follow-up visit</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (12.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1409" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1446" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemorrhagic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Anaemia of malignant disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Heparin-induced thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemolytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Anaemia megaloblastic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Anaemia of chronic disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Anaemia vitamin b12 deficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemorrhagic diathesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hypochromic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hypoprothrombinaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Microcytic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Nephrogenic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemorrhagic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemolysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Polycythaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Thrombocytopenic purpura</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Sick sinus syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Left ventricular dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Mitral valve disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Right ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Atrioventricular block second degree</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cardiac amyloidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cardiac perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dressler's syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Sinoatrial block</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Hydrocele</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastrointestinal angiodysplasia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Phimosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastrointestinal angiodysplasia haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dermoid cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Muscular dystrophy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Adenomatous polyposis coli</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bicuspid aortic valve</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Sudden hearing loss</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Vestibular disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hearing impaired</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Meniere's disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Deafness neurosensory</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Ear disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Tympanic membrane disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Vertigo labyrinthine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Toxic nodular goitre</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Autoimmune thyroiditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hyperaldosteronism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hyperparathyroidism secondary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hypopituitarism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Thyroiditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Eye haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Retinal vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Episcleritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pupils unequal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Retinal disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Retinal vascular thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Retinoschisis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Angle closure glaucoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Optic ischaemic neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Eye disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Visual impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Colonic polyp</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastritis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Peptic ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haematoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Abdominal strangulated hernia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Food poisoning</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Rectal polyp</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastrointestinal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Colitis ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Enterocolitis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Mechanical ileus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Femoral hernia, obstructive</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Intestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Volvulus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Subileus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Diverticulitis intestinal haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Enterocolitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastroduodenitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Intra-abdominal haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Retroperitoneal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Small intestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Diverticular perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastroduodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemorrhagic erosive gastritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Impaired gastric emptying</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Irritable bowel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Umbilical hernia, obstructive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Acute abdomen</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Anal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Barrett's oesophagus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastric mucosal lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastric perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastric polyps</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastric ulcer perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastrointestinal necrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastrooesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gingival bleeding</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hernial eventration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Ileus paralytic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Intestinal infarction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Intestinal polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Mallory-weiss syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Megacolon</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Mesenteric occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Oesophageal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Oesophageal perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Oesophageal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Oesophageal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Peritoneal adhesions</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Peritoneal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Polyp colorectal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Rectal prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Rectal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Salivary gland calculus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Small intestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Swollen tongue</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Tooth disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Tooth loss</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Reflux oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Anal fissure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Large intestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Abdominal adhesions</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Abdominal hernia obstructive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Anal prolapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Colonic pseudo-obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gallstone ileus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastric disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastrointestinal inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastrointestinal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Inguinal hernia, obstructive</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Large intestinal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lumbar hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pancreatitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pancreatitis necrotising</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Periodontitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Radicular cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Reflux gastritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Sigmoiditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hernia obstructive</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Catheter site pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Implant site effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Swelling</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Catheter thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Drowning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Fat tissue increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Perforated ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Puncture site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Biliary colic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hepatic steatosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Jaundice cholestatic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bile duct obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cholangitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hepatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hepatocellular injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bile duct stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cholelithiasis obstructive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cirrhosis alcoholic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gallbladder disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hepatitis alcoholic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hepatotoxicity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Liver disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Post cholecystectomy syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hepatic cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hepatitis toxic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hepatosplenomegaly</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hydrocholecystis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Allergy to arthropod sting</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="141" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="167" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haematoma infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Appendicitis perforated</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Clostridial infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Infective exacerbation of chronic obstructive airways disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Post procedural infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Arthritis infective</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pulmonary sepsis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lung infection pseudomonal</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pulmonary tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Anal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Labyrinthitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Vestibular neuronitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bacterial pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Necrotising fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Post procedural sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Acarodermatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Acute tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Anogenital warts</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Beta haemolytic streptococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Biliary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bronchitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Diarrhoea infectious</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Encephalitis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Enterocolitis infectious</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Escherichia infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Eye infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastrointestinal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Genitourinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hepatitis e</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Infected skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Injection site infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Intervertebral discitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Perirectal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Peritoneal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pneumonia escherichia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pneumonia klebsiella</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pneumonia legionella</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pneumonia streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pseudomembranous colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Skin bacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Staphylococcal toxaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Streptococcal bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Tetanus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Vulval abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Wound infection staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Chronic sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dengue fever</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gallbladder empyema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pneumonia primary atypical</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Abdominal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Abscess neck</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Appendiceal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Borrelia infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Breast abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Carbuncle</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cholangitis suppurative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Diabetic foot infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Diabetic gangrene</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Empyema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Fungal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastroenteritis salmonella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Herpes zoster ophthalmic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lymphangitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Nosocomial infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Parotitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Perinephric abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pharyngeal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pneumonia influenzal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pneumonia pneumococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Respiratory syncytial virus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Sialoadenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Splenic abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis septic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Toxic shock syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="29" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Therapeutic agent toxicity</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Operative haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Drug toxicity</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dislocation of joint prosthesis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Traumatic haematoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Anaemia postoperative</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Alcohol poisoning</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Traumatic intracranial haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Chest injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Extradural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Muscle rupture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Open fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Traumatic brain injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Sternal fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Subdural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Face injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Fractured coccyx</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Meniscus lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Multiple injuries</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Open wound</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Post-traumatic pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Radiation mucositis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Abdominal wound dehiscence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Anastomotic leak</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Back crushing</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage traumatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Device failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dural tear</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Epiphyseal fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Fibula fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Forearm fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Poisoning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Post procedural stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Tooth fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Transplant failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Wound complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pneumothorax traumatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cervical vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Traumatic fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Accidental poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bladder injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Brain contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Complication of device insertion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cystitis radiation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Eye injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Heat exhaustion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Joint sprain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Ligament injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pacemaker complication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Post procedural haematuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Postoperative adhesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Postoperative ileus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Procedural hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pseudomeningocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pubic rami fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Scapula fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Subcutaneous haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Thoracic vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Anticoagulation drug level above therapeutic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Aspiration bronchial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Prostatic specific antigen increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cachexia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Electrolyte imbalance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemosiderosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Neuroglycopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Underweight</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="58" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="48" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gouty arthritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemarthrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Kyphoscoliosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Osteitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Osteochondrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Sympathetic posterior cervical syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Osteoporotic fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dupuytren's contracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Foot deformity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Periarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Arthritis enteropathic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Fibromyalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Mobility decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Muscle haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Neuropathic arthropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Periostitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Senile ankylosing vertebral hyperostosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Senile osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Vertebral wedging</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="34" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Prostatic adenoma</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Non-hodgkin's lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Colon neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Colon cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Brain neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lung neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Renal cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Skin cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Uterine cancer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Endometrial cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gallbladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Multiple myeloma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Prostate cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma pancreas</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Ovarian cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Thyroid cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bile duct cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Breast cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Rectosigmoid cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Acute leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bladder papilloma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Colorectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Malignant pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Metastatic gastric cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer stage iv</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Adrenal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Neoplasm prostate</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Renal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Renal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Biliary neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Breast neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastric neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Metastasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Plasmacytoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Prostate cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Abdominal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Adrenal adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>B-cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Benign anorectal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Benign renal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bladder cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bone cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bone neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Breast cancer female</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Carcinoid tumour of the stomach</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cerebellar tumour</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cervix carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cholesteatoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Colorectal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cystosarcoma phyllodes</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Diaphragm neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Fibrosarcoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastric cancer stage iv</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Glioblastoma multiforme</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Intestinal adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Large intestine carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Leiomyosarcoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Liposarcoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lymph node cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Mediastinum neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Melanocytic naevus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Mesothelioma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Mesothelioma malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Metastatic renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Nasal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Neurofibroma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Ovarian fibroma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pancreatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pancreatic neuroendocrine tumour</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pleural mesothelioma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Rectal adenoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Rectal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Skin cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Tongue neoplasm malignant stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Vulval cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Myeloproliferative disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Benign ovarian tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Diffuse large b-cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastrointestinal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Salivary gland neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Thyroid neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Acute lymphocytic leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of adrenal gland</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Biliary cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Brain neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Carcinoid tumour pulmonary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Chronic leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Colon cancer stage ii</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Colon cancer stage iv</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Duodenal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Endometrial cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Fibroma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gastrointestinal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemangiopericytoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Keratoacanthoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Laryngeal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Leiomyoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Leiomyosarcoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lentigo maligna stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Malignant melanoma in situ</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Mantle cell lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Meningioma benign</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Metastatic malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Neoplasm skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Oral neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Papilloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pharyngeal cancer stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Prostate cancer stage iii</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Salivary gland adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Sarcoma uterus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Small intestine carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Thyroid adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Tongue neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Vascular neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemorrhagic stroke</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dementia alzheimer's type</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Polyneuropathy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cervical root pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Vascular encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Vascular dementia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemorrhagic transformation stroke</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cervicobrachial syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dizziness postural</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Encephalitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Intercostal neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Ageusia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Anosmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Autonomic nervous system imbalance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Brachial plexopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Brain injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Carotid artery occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cauda equina syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cerebellar syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cerebral haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Depressed level of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Extrapyramidal disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hypokinesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Multiple sclerosis relapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Neurological symptom</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Simple partial seizures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Thalamus haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Trigeminal neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Intracranial haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Paresis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Spinal cord compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Vertebrobasilar insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Anoxic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Brain oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cerebral cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic coma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Mental impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Mononeuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Myasthenia gravis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Myxoedema coma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Nerve compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Normal pressure hydrocephalus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Optic neuritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Phantom pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Postictal paralysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Radicular syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Status epilepticus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Alcohol abuse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Stress</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Alcoholism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Delusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Delusional disorder, persecutory type</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Depression suicidal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Mental disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Somatisation disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Delusional disorder, unspecified type</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Depressive symptom</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Disorientation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Nervousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Neurosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Paranoia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Post-traumatic stress disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Schizophrenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Schizophrenia, paranoid type</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" subjects_affected="35" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemorrhage urinary tract</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Calculus ureteric</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Urethral stenosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Renal cyst</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Urinary bladder polyp</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Urinary tract obstruction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cystitis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Ureteric stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Anuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Acute prerenal failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bladder neck obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Calculus bladder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cystitis noninfective</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Diabetic nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Obstructive uropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Polyuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Renal disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Urinary bladder haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Urinary tract disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Stress urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Azotaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bladder obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bladder stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cystitis ulcerative</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Glomerulonephritis chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Neurogenic bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Renal tubular necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Urethral fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Urethral meatus stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Uterine polyp</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Prostatomegaly</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Prostatism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Colpocele</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Endometrial hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Endometrial hypertrophy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Fibrocystic breast disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Genital prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Uterine cervical erosion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Adenomyosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Breast haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cervical polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Gynaecomastia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Peyronie's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Prostatic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Prostatic haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Rectocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Spermatocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Uterine haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Varicocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="45" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="40" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bronchitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bronchial disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lung disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Respiratory arrest</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Nasal polyps</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Emphysema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Foreign body aspiration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Lung infiltration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Nasal mucosa atrophy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pulmonary congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bronchial hyperreactivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bronchial obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Obstructive airways disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pulmonary amyloidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pulmonary haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pulmonary hilum mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pulmonary mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Sinus polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Thoracic haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Vocal cord disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dermatitis atopic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemorrhage subcutaneous</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pemphigoid</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Purpura</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Pustular psoriasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Skin necrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Skin ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Acanthosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dermal cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Ecchymosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Skin nodule</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Toxic skin eruption</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Bedridden</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Elderly</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Social stay hospitalisation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Walking disability</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Hospitalisation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Cholecystectomy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Colon operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemorrhoid operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hip arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Knee arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Retinal operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Wound drainage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Alcohol detoxification</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dacryocystorhinostomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Eventration procedure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Intestinal stoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Intraocular lens repositioning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Renal cyst excision</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bleeding varicose vein</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Varicose vein</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis obliterans</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Vasculitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Extremity necrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hypoperfusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Iliac vein occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Peripheral embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Temporal arteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Thrombosed varicose vein</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Venous thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Wound haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Haemorrhagic infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Aneurysm arteriovenous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Aortic rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Arterial disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Peripheral artery aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Venous insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (12.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3303" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="3277" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Any cardiac disorders</sub_title>
                <counts group_id="E1" subjects_affected="444" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="455" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Any eye disorders</sub_title>
                <counts group_id="E1" subjects_affected="345" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="336" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Any gastrointestinal disorders</sub_title>
                <counts group_id="E1" subjects_affected="1044" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1059" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Any general disorders and administration site conditions</sub_title>
                <counts group_id="E1" subjects_affected="836" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="858" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="259" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="302" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Any infections and infestations</sub_title>
                <counts group_id="E1" subjects_affected="1369" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="1369" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="255" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="251" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="225" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="238" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Any injury, poisoning and procedural complications</sub_title>
                <counts group_id="E1" subjects_affected="569" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="582" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Any investigations</sub_title>
                <counts group_id="E1" subjects_affected="276" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="297" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Any metabolism and nutrition disorders</sub_title>
                <counts group_id="E1" subjects_affected="383" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="384" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Any musculoskeletal and connective tissue disorders</sub_title>
                <counts group_id="E1" subjects_affected="884" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="930" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Any neoplasms benign, malignant and unspecified (incl cysts and polyps)</sub_title>
                <counts group_id="E1" subjects_affected="296" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="358" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Any nervous system disorders</sub_title>
                <counts group_id="E1" subjects_affected="1067" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="917" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="529" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="399" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Any psychiatric disorders</sub_title>
                <counts group_id="E1" subjects_affected="260" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="275" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Any renal and urinary disorders</sub_title>
                <counts group_id="E1" subjects_affected="344" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="282" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Any respiratory, thoracic and mediastinal disorders</sub_title>
                <counts group_id="E1" subjects_affected="772" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="782" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="333" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="330" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Any skin and subcutaneous tissue disorders</sub_title>
                <counts group_id="E1" subjects_affected="464" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="465" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Any vascular disorders</sub_title>
                <counts group_id="E1" subjects_affected="784" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="686" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="350" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="193" subjects_at_risk="4498"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="209" subjects_at_risk="4518"/>
                <counts group_id="E2" subjects_affected="273" subjects_at_risk="4498"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Publication of the study will be made jointly in the name of all wholehearted collaborators. Other papers will be authored based on the contributions of the individuals to the overall study. Substudies with scientific merit which have received prior approval from the Steering Committee (SC) may be published in the names of the contributing investigators. A copy of all manuscripts will be provided to the sponsors for their review. The final decision to publish articles will be made by the SC.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>International Clinical Development, Clinical Study Director</name_or_title>
      <organization>sanofi-aventis</organization>
      <email>GV-Contact-us@sanofi-aventis.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

